Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 24;188(15):3927-3941.e13.
doi: 10.1016/j.cell.2025.05.014. Epub 2025 Jun 6.

Microbiome mismatches from microbiota transplants lead to persistent off-target metabolic and immunomodulatory effects

Affiliations

Microbiome mismatches from microbiota transplants lead to persistent off-target metabolic and immunomodulatory effects

Orlando DeLeon et al. Cell. .

Abstract

Fecal microbiota transplant (FMT) is an increasingly used intervention, but its suitability to restore regional gut microbiota, particularly in the small bowel (SB), must be questioned because of its predominant anaerobic composition. In human subjects receiving FMT by upper endoscopy, duodenal engraftment of anaerobes was observed after 4 weeks. We hypothesized that peroral FMTs create host-microbe mismatches that impact SB homeostasis. To test this, antibiotic-treated specific-pathogen-free (SPF) mice were given jejunal, cecal, or fecal microbiota transplants (JMTs, CMTs, or FMTs, respectively) and studied 1 or 3 months later. JMT and FMT altered regional microbiota membership and function, energy balance, and intestinal and hepatic transcriptomes; JMT favored host metabolic pathways and FMT favored immune pathways. MTs drove regional intestinal identity (Gata4, Gata6, and Satb2) and downstream differentiation markers. RNA sequencing (RNA-seq) of metabolite-exposed human enteroids and duodenal biopsies post-FMT confirmed transcriptional changes in mice. Thus, regional microbial mismatches after FMTs can lead to unintended consequences and require rethinking of microbiome-based interventions.

Keywords: FMT; engraftment; intestine; jejunum; metabolism; microbiome; mucosa; regional ecosystem; regional mismatch; small bowel microbiota.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests The authors declare no competing interests.

References

    1. Bartlett JG (2002). Antibiotic-Associated Diarrhea. N. Engl. J. Med 346, 334–339. 10.1056/NEJMcp011603. - DOI - PubMed
    1. Baunwall SMD, Lee MM, Eriksen MK, Mullish BH, Marchesi JR, Dahlerup JF, and Hvas CL (2020). Faecal microbiota transplantation for recurrent Clostridioides difficile infection: An updated systematic review and meta-analysis. EClinicalMedicine 29–30, 100642. 10.1016/j.eclinm.2020.100642. - DOI - PMC - PubMed
    1. Ianiro G, Bibbò S, Porcari S, Settanni CR, Giambò F, Curta AR, Quaranta G, Scaldaferri F, Masucci L, Sanguinetti M, et al. (2021). Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: experience of a large-volume European FMT center. Gut Microbes 13, 1994834. 10.1080/19490976.2021.1994834. - DOI - PMC - PubMed
    1. Yadegar A, Pakpoor S, Ibrahim FF, Nabavi-Rad A, Cook L, Walter J, Seekatz AM, Wong K, Monaghan TM, and Kao D. (2023). Beneficial effects of fecal microbiota transplantation in recurrent Clostridioides difficile infection. Cell Host Microbe 31, 695–711. 10.1016/j.chom.2023.03.019. - DOI - PMC - PubMed
    1. Zhang J., Zhu G., Wan L., Liang Y., Liu X., Yan H., Zhang B., and Yang G. (2023). Effect of fecal microbiota transplantation in children with autism spectrum disorder: A systematic review. Front. Psychiatry 14, 1123658. 10.3389/fpsyt.2023.1123658. - DOI - PMC - PubMed

Substances

LinkOut - more resources